Molecular adsorbents recirculating system dialysis in children with cholestatic pruritus

Pediatric Nephrology

Volumn 27, Issue 5, 2012, Pages 829-834

  Schaefer, Betti ^a   Schaefer, Franz ^a   Wittmer, Dieter ^a   Engelmann, Guido ^a   Wenning, Daniel ^a   Schmitt, Claus Peter ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Center for Pediatrics and Adolescent Medicine   (Germany)

Author keywords

Bile acids; Cholestatic pruritus; Molecular adsorbents recirculating system; Numeric rating scale; Pediatrics

Indexed keywords

BILE ACID; BILIRUBIN; ENZYME INDUCING AGENT; OPIATE ANTAGONIST; SEROTONIN ANTAGONIST; URSODEOXYCHOLIC ACID;

ADOLESCENT; ALBUMIN DIALYSIS; ARTICLE; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHILD; CHOLESTASIS; CHOLESTATIC PRURITUS; DRUG TREATMENT FAILURE; HUMAN; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN PRURITUS; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; BILE ACIDS AND SALTS; BILIARY ATRESIA; BILIRUBIN; CHILD; CHOLESTASIS; FEMALE; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECII; POLYCYSTIC KIDNEY DISEASES; PRURITUS; QUALITY OF LIFE; RENAL DIALYSIS; SORPTION DETOXIFICATION;

EID: 84863483806     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-2058-8     Document Type: Article

References (40)

1. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G (2001) Health-related quality of life in chronic liver disease: The impact of type and severity of disease. Am J Gastroenterol 96:2199-2205 (Pubitemid 32660918)
2. Jones EA, Bergasa NV (1996) Why do cholestatic patients itch? Gut 38:644-645 (Pubitemid 26167467)
3. Régina A, Demeule M, Laplante A, Jodoin J, Dagenais C, Berthelet F, Moghrabi A, Béliveau R (2001) Multidrug resistance in brain tumors: Roles of the blood-brain barrier. Cancer Metastasis Rev 20:13-25 (Pubitemid 34074674)
4. Dagenais C, Ducharme J, Pollack GM (2001) Uptake and efflux of the peptidic delta-opioid receptor agonist. Neurosci Lett 301:155-158
5. Banks WA, Kastin AJ (1990) Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol 259:1-10
6. Hofmann AF (2002) Cholestatic liver disease: Pathophysiology and therapeutic options. Liver 22:14-19
7. Franco J (1999) Pruritus. Curr Treat Options Gastroenterol 2:451-456
8. Glasova H, Beuers U (2002) Extrahepatic manifestations of cholestasis. J Gastroenterol Hepatol 17:938-948
9. Bergasa NV (2005) The pruritus of cholestasis. J Hepatol 43:1078-1088 (Pubitemid 41627995)
10. Hoek FJ, Grijm R, Sanders GT, Tytgat GN, Wilmink JM (1982) Removal of bile acids from the blood by hemodialysis with a polyacrylonitril membrane: Treatment of pruritus of cholestatic disease. Digestion 23:135-140 (Pubitemid 12161392)
11. Omokawa S, Yamashita M, Malchesky PS, Koo AP, Matsushita M, Nosè Y (1990) Therapeutic plasmapheresis for cholestatic liver diseases: Study of 9 cases. Prog Clin Biol Res 337:233-236
12. Geerdink P, Snel P, van Berge Henegouwen GP, Huybregts A, Tangerman A, Kunst VA, van Tongeren JH (1978) Treatment of intractable pruritus in patients with cholestatic jaundice by plasma exchange and plasma perfusion. Neth J Med 21:239-244 (Pubitemid 9090655)
13. Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R (2003) Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 38:24-31 (Pubitemid 36078520)
14. Sorkine P, Ben Abraham R, Szold O, Biderman P, Kidron A, Merchav H, Brill S, Oren R (2001) Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 29:1332-1336 (Pubitemid 32641793)
15. Schmidt LE, Svendsen LB, Sørensen VR, Hansen BA, Larsen FS (2001) Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure. Liver Transpl 7:709-712 (Pubitemid 32771470)
16. Schmidt LE, Wang LP, Hansen BA, Larsen FS (2003) Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transpl 9:290-297 (Pubitemid 36322332)
17. Mitzner SR, Klammt S, Peszynski P, Hickstein H, Korten G, Stange J, Schmidt R (2001) Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 5:417-422 (Pubitemid 34033340)
18. Kantola T, Mäklin S, Koivusalo AM, Räsänen P, Rissanen A, Roine R, Sintonen H, Höckerstedt K, Isoniemi H (2010) Costutility of molecular adsorbent recirculating system treatment in acute liver failure. World J Gastroenterol 16:2227-2234
19. Parés A, Herrera M, Avilés J, Sanz M, Mas A (2010) Treatment of resistant pruritus from cholestasis with albumin dialysis: Combined analysis of patients from three centers. J Hepatol 53:307-312
20. Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, Wiedermann CJ, Joannidis M (2004) Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl 10:107-114 (Pubitemid 38885901)
21. Novelli G, Rossi M, Poli L, Predagostini R, Iappelli M, Morabito V, Lai Q, Novelli L, Mennini G, Corradini SG, Berloco PB (2006) Intractable pruritus in patients with hepatitis C virus. Transplant Proc 38:1089-1091 (Pubitemid 43815910)
22. Montero JL, Pozo JC, Barrera P, Fraga E, Costán G, Domínguez JL, Muntané J, Rodriguez-Ariza A, Pleguezuelo M, Rufián S, López-Cillero P, de la Mata M (2006) Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). Transplant Proc 38:2511-2513 (Pubitemid 44693708)
23. Doria C, Mandalá L, Smith J, Vitale CH, Lauro A, Gruttadauria S, Marino IR, Foglieni CS, Magnone M, Scott VL (2003) Effect of molecular adsorbent recirculating system in hepatitis C virusrelated intractable pruritus. Liver Transpl 9:437-443 (Pubitemid 36443060)
24. Javouhey E, Ranchin B, Lachaux A, Boillot O, Martin X, Floret D, Cochat P (2009) Long-lasting extracorporeal albumin dialysis in a child with end-stage renal disease and severe cholestasis. Pediatr Transplant 13:235-239
25. Möller HJ (2009) Standardised rating scales in psychiatry: Methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry 10:6-26
26. Yerushalmi B, Sokol RJ, Narkewicz MR, Smith D, Karrer FM (1999) Use of rifampin for severe pruritus in children with chronic cholestasis. J Pediatr Gastroenterol Nutr 29:442-447 (Pubitemid 30346365)
27. Keppler D, Leier I, Jedlitschky G (1997) Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378:787-791 (Pubitemid 27388938)
28. Meier PJ, Stieger B (2002) Bile salt transporters. Annu Rev Physiol 64:635-661 (Pubitemid 34259244)
29. Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, Schmitt CP (2011) Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant. doi:10.1093/ndt/gfr115
30. Macia M, Avilés J, Navarro J, Morales S, García J (2003) Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis. Am J Med 114:62-64 (Pubitemid 36126518)
31. Bellmann R, Feistritzer C, Zoller H, Graziadei IW, Schwaighofer H, Propst A, Wiedermann CJ, Joannidis M (2004) Treatment of intractable pruritus in drug induced cholestasis with albumin dialysis: A report of two cases. ASAIO J 50:387-391 (Pubitemid 38917890)
32. Vanholder R, Van Laecke S, Glorieux G (2008) What is new in uremic toxicity? Pediatr Nephrol 23:1211-1221
33. Lloyd-Thomas HG, Sherlock S (1952) Testosterone therapy for the pruritus of obstructive jaundice. Br Med J 2:1289-1291
34. Auth MK, Kim HS, Beste M, Bonzel KE, Baumann U, Ballauff A, Wallot M, Borchers T, Vester U, Grasemann C, Hauffa B, Hoyer PF, Gerken G, Voit T (2005) Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr 40:54-59 (Pubitemid 40180058)
35. Riggio O, Mannaioni G, Ridola L, Angeloni S, Merli M, Carlà V, Salvatori FM, Moroni F (2010) Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: A study on the pathophysiology of hepatic encephalopathy. Am J Gastroenterol 105:1374-1381
36. Silver RM, Heyes MP, Maize JC, Quearry B, Vionnet-Fuasset M, Sternberg EM (1990) Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 322:874-881 (Pubitemid 20108376)
37. Meijers BK, Verhamme P, Nevens F, Hoylaerts MF, Bammens B, Wilmer A, Arnout J, Vanrenterghem Y, Evenepoel P (2007) Major coagulation disturbances during fractionated plasma separation and adsorption. Am J Transplant 7:2195-2199 (Pubitemid 47247056)
38. Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer H, Krenn CG, Unger S, Hetz H (2006) Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: An observational study. Crit Care 10:24
39. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Müllhaupt B, Renner EL (2007) Artificial liver support with the molecular adsorbent recirculating system: Activation of coagulation and bleeding complications. Liver Int 27:475-484 (Pubitemid 46534569)
40. Doria C,Mandalà L, Smith JD, Caruana G, Scott VL, Gruttadauria S, Magnone M, Marino IR (2004) Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 18:365-371 (Pubitemid 39077068)